We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Inovio Starts Dosing of COVID-19 Vaccine in Mid-Stage Study
Inovio Starts Dosing of COVID-19 Vaccine in Mid-Stage Study
Inovio has dosed the first participant in the phase 2 segment of its phase 2/3 trial evaluating COVID-19 vaccine candidate INO-4800, funded by the Department of Defense (DoD).